Medium- and Long-Term Urinary and Sexual Outcomes in Patients Who Underwent Surgery for Hirschsprung Disease in the Auvergne-Rhône-Alpes Region and at Marseille University Hospital Between 2000 and 2018
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 556
- 试验地点
- 5
- 主要终点
- To describe medium- and long-term urinary sequelae in patients aged 8-26 years who underwent surgery for Hirschsprung disease during early childhood.
研究概览
简要总结
Hirschsprung disease is a rare congenital disorder affecting the gastrointestinal tract of newborns. It is caused by the absence of enteric ganglion cells in a segment of the large intestine, preventing normal bowel function and leading to intestinal obstruction. The only effective treatment is surgical, usually performed during the first months or years of life, and consists of resecting the affected bowel segment and reconnecting the healthy intestine.
Advances in surgical techniques have enabled most children with Hirschsprung disease to achieve normal growth and development. However, surgery is performed in an anatomical region containing nerves and structures that are essential for normal bladder and sexual function. Although previous studies have demonstrated that some patients continue to experience long-term bowel dysfunction after surgery, the potential long-term effects on urinary function and sexual health during childhood, adolescence, and adulthood remain insufficiently investigated.
The primary objective of this study is to determine the prevalence and characteristics of long-term urinary symptoms in patients who underwent surgery for Hirschsprung disease during early childhood. Secondary objectives are to assess sexual function, overall quality of life, and long-term bowel function. In addition, the investigators aim to compare these outcomes according to the surgical technique used, as several operative approaches are currently available and none has yet been shown to be superior in preventing long-term sequelae.
the investigators hypothesize that a clinically relevant proportion of patients-approximately 10%-experience persistent urinary symptoms years after surgery, despite these symptoms being infrequently assessed and rarely included in routine long-term follow-up.
This study is intended for individuals aged 7 to 25 years who underwent surgery for Hirschsprung disease between 2000 and 2018 at one of the five participating university hospitals: Grenoble, Lyon, Saint-Étienne, Clermont-Ferrand, and Marseille. Eligible participants will be contacted by telephone and invited to participate. Those who provide informed consent (and assent/parental consent when applicable) will receive a secure email link to complete online questionnaires assessing urinary symptoms, sexual function (when age-appropriate), quality of life, and bowel function. These validated questionnaires have been widely used in previous studies and require approximately 15-20 minutes to complete. No study visits, medical examinations, or additional follow-up are planned as part of this research; participation consists solely of completing the questionnaires.
The findings of this study will improve our understanding of the long-term urinary and sexual sequelae associated with Hirschsprung disease surgery. Ultimately, they may contribute to the development of more systematic long-term postoperative follow-up strategies, enabling earlier identification and improved management of urinary and sexual dysfunction in children as they progress through adolescence and into adulthood.
详细描述
- Study Design
This research is a Category 3 human research study (non-interventional research involving human participants). It is a multicenter, prospective, observational, and descriptive study combining a retrospective review of clinical and surgical data extracted from medical records with a prospective collection of patient-reported outcomes using standardized self-administered questionnaires. No additional procedures, examinations, or study visits are required. All clinical and surgical data are obtained from routine medical records, while the only study-specific procedure consists of completing online questionnaires.
Eligible patients are identified from the databases of the five participating university hospitals (Grenoble, Lyon, Saint-Étienne, Clermont-Ferrand, and Marseille) using procedural codes for pull-through surgery (French CCAM codes including HJFA001, HJFA002, HJFA004, HJFA005, HJFA007, HJFA011, HJFA017, and HJFC031) together with the diagnosis code for Hirschsprung disease (ICD-10: Q43.1). Electronic medical records are subsequently reviewed to confirm eligibility based on histopathological findings, operative reports, and the absence of syndromic forms, total colonic aganglionosis, or small-bowel aganglionosis. 2. Study Procedures
The participant pathway consists of the following steps:
An initial telephone call from the local investigator to provide oral information about the study (up to three contact attempts).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 7 Years 至 25 Years(Child, Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Biopsy-confirmed Hirschsprung disease treated surgically between 2000 and 2018, regardless of the pull-through technique used.
- •Surgery performed at one of the five participating university hospitals (Grenoble, Lyon, Saint-Étienne, Clermont-Ferrand, or Marseille).
- •Male or female participants.
- •Aged 7 to 25 years at the time of study inclusion.
- •No objection to participation obtained from the participant or, for minors, from the legal representative, in accordance with French regulations.
- •Affiliation with the French national health insurance system.
排除标准
- •Syndromic Hirschsprung disease (e.g., Down syndrome, Waardenburg syndrome, or Multiple Endocrine Neoplasia type 2).
- •Total colonic aganglionosis.
- •Small-bowel aganglionosis.
- •Major congenital urogenital malformation unrelated to Hirschsprung disease (e.g., bladder exstrophy or posterior urethral valves).
- •Deceased before study inclusion.
- •Unable to be contacted despite repeated attempts.
- •Individuals not eligible for biomedical research under Articles L1121-5 to L1121-8 of the French Public Health Code.
结局指标
主要结局
To describe medium- and long-term urinary sequelae in patients aged 8-26 years who underwent surgery for Hirschsprung disease during early childhood.
时间窗: Day 1
Primary Outcome Measure The primary outcome is the assessment of lower urinary tract symptoms (LUTS) using age- and sex-specific International Consultation on Incontinence Questionnaire (ICIQ) instruments. The following questionnaires will be used according to the participant's age and sex: ICIQ-CLUTS for children and adolescents (\<18 years); ICIQ-FLUTS for adult women; ICIQ-MLUTS for adult men. Children and Adolescents (\<18 years) Instrument: International Consultation on Incontinence Questionnaire - Children's Lower Urinary Tract Symptoms (ICIQ-CLUTS) Population: Children and adolescents. Questionnaire versions: Parent-proxy version for children younger than 9 years. Self-administered version for children aged 9 years or older. Number of items: 12. Completion time: Approximately 4-5 minutes. Scoring: Total score: 0-24. Filling symptoms subscore: 0-12. Voiding symptoms subscore: 0-4. Urinary incontinence subscore: 0-8.
次要结局
- To evaluate long-term erectile function in male patients aged 16-25 years who underwent surgery for Hirschsprung disease during childhood.(Day 1.)
- To evaluate long-term female sexual function in female patients aged 16-25 years who underwent surgery for Hirschsprung disease during childhood.(Recall period: Previous 4 weeks. Time Frame: Day 1.)
- To evaluate medium- and long-term health-related quality of life in patients aged 8-25 years..(Day 1)
- To evaluate medium- and long-term bowel function in patients aged 8-26 years who underwent surgery for Hirschsprung disease during childhood(Day 1)
- Lower urinary tract symptoms assessed using age- and sex-appropriate International Consultation on Incontinence Questionnaire (ICIQ) according to surgical technique(Day 1)
- Bowel Function Score (BFS) according to surgical technique (Swenson, Soave, or Duhamel pull-through procedure)(Day 1)
- Pediatric Quality of Life Inventory Version 4.0 Short Form 15 (PedsQL™ 4.0 SF15) total score according to surgical technique (Swenson, Soave, or Duhamel pull-through procedure)(Day 1)
- International Index of Erectile Function-5 (IIEF-5) total score according to surgical technique(Day 1)
- Female Sexual Function Index (FSFI) total score according to surgical technique(Day 1)
